Elizabeth I Buchbinder

15PUBLICATIONS
100CO-AUTHORS
Tumour immunologyPredictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

|Jun 23, 2026
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

|Feb 13, 2026
Uveal Melanoma: Biology, Prognostication, and Emerging Therapies to Outsmart an Immune-Cold Melanoma.

Danielle Brazel, Elizabeth Buchbinder

|Dec 31, 2025
Mechanisms of tumor persistence in metastatic melanoma following successful immunotherapy.

Yingxiao Shi, Zoltan Maliga, Tuulia Vallius

|Dec 04, 2025
Systemic Anticancer Therapy Timelines Extraction From Electronic Medical Records Text: Algorithm Development and Validation.

Jiarui Yao, Eli Goldner, Harry Hochheiser

|Aug 03, 2025
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study.

Mohammed M Milhem, Yousef Zakharia, Diwakar Davar

Pageof 3

Frequent Collaborators

3 joint publications

Ryan J Sullivan

2 joint publications

Patrick Ott

2 joint publications

Christine G Lian

2 joint publications

Alexander Noor Shoushtari